Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

A fertile half

Monash IVF
3:27pm
February 23, 2024
MVF provided a strong 1H24 result, with underlying NPAT up 19% and at the top end of guidance range. Structural growth drivers in IVF remain in play, with MVF continuing to gain market share and grow above industry (through both organic and inorganic growth). We have upgraded our NPAT in line with guidance, up 2.7% in FY24 and 3.9% in FY25. We maintain our ADD recommendation with a TP of $1.55 (was $1.50).

Sales targets are aggressive and achievable

Avita Medical
3:27pm
February 23, 2024
AVH’s CY23 results were in line with guidance, the highlight being 46% product revenue growth. AVH has reconfirmed CY24 revenue growth of ~63%. Importantly, management has called out its expectation of achieving profitability by 3QCY25. Given management’s track record we see this target as achievable and we expect the market to reward the company well head of this timeline. Key to achieving this target is the approval of RECELL GO which is expected on 31st May 2024. This is a key milestone. We have made no changes to forecasts, TP, or our ADD recommendation. Today’s share price weakness is a great buying opportunity. AVH is a key pick.

Mid-year could potentially provide the key catalyst

PEXA Group
3:27pm
February 23, 2024
PXA’s 1H24 Group NPATA (A$15m) was down -36% on the pcp, and slightly below consensus (A$17m). This result had been heavily pre-announced and headline figures were largely as expected with FY24 guidance re-affirmed (albeit PXA Exchange margins are tracking slightly above the top end of the range). The key stock catalyst here remains the launch of the 24- hour UK refinance product in the middle of 2024, which management says remains on track. We make nominal changes to our PXA FY24F/FY25F EBITDA forecasts (+1%-2%) but our NPATA forecasts fall by -22%/-4% on higher non-operating items, e.g. specified items and D&A, etc. Our valuation rises to A$12.19 on higher future operating earnings and a valuation roll-forward. HOLD maintained.

1H24 earnings: Lace up

Accent Group
3:27pm
February 23, 2024
EBIT was 4% lower than forecast and down 11% on a pro forma basis. AX1 said it does not believe consumer demand has changed “fundamentally”, but there is a “little bit of softness” at present. AX1 has performed best where its brands are “hot” (such as HOKA). Against elevated comps, LFLs were resilient at (0.6)% in the first half and have started 2H24 at a similar pace. The comps get less demanding as the half goes on and we expect positive LFLs in 2H24 as a whole. This resilience is a function of the portfolio effect and strong market position. We have lowered our EBIT estimates by 2% in FY24 and FY25 due to higher D&A and retain an Add rating and $2.30 target price.

1H mixed- the end of “market dislocation”?

Ansell
3:27pm
February 23, 2024
1H was mixed, with an inline double-digit earnings decline, but on softer revenue and underlying profit. OPM expanded in Industrial on manufacturing efficiencies and carryover pricing, but was more than offset by contracting margins in Healthcare on continued inventory destocking and slowing of production to address inflated inventories. While a 2H recovery appears reasonable, as a proportion of earnings is driven by cost-outs/efficiencies, we remain cautious on the end of this multi-year “market dislocation” especially as gains are reliant on exogenous factors (eg supportive macros and limited customer destocking), while APIP unfolds over time. While FY24-26 estimates move lower, we roll forward valuation multiples with our DCF/SOTP PT increasing to A$22.53. Hold.

Improved cost control sees margin expansion

Wagners
3:27pm
February 23, 2024
Whilst the result was largely pre-released, the underlying 1HFY24 EBIT of $20.0m reflects a significant improvement on the $4.4m achieved in the pcp. The construction materials division was the primary driver, where EBIT increased 95% on the pcp as improved prices, volumes and cost control saw EBIT margins increase to 11.8% (1H23: 7.4%). The result really points to the cyclical nature of the industry and WGN’s leverage to an improving cycle. The positive operating environment, combined with continued M&A across the industry (ABC, BLD, CSR all receiving bids) all bode well for WGN. On this basis we have changed our recommendation to an ADD rating (previously Speculative Buy) reflecting lower earnings and valuation risk, whilst leaving our target price unchanged at $1.15/sh.

Quite some ground to cover in 2H24

Objective Corporation
3:27pm
February 22, 2024
OCL delivered a solid 1H24 result, with margin improvements (to near FY21 levels on a like-for-like basis), overshadowing softness in 1H24 ARR growth (+10%). Management reiterated its 15% Net ARR growth target for FY24. Based on OCL’s 1H24 ARR exit rate of $97.5m, this implies the group will need to deliver a record half of ARR growth equating to a 2H24 uplift of ~$10.8m. Following this result make modest changes of +1.6%/-1.4%/-3.2% to our EBITDA forecasts in FY24-FY26F. Rolling forward our blended DCF/EV/EBITDA valuation sees our price target revised to $14.00ps (from $14.35).

Not as clean as hoped

Medibank
3:27pm
February 22, 2024
MPL’s 1H24 underlying NPAT (A$263m) was +16% on the pcp, and -1% below company-compiled consensus (A$266m).  We saw this as a bit of a mixed result overall. Whilst the Health Insurance (HI) claims environment remains favourable, revised FY24 HI policyholder guidance and management expense growth guidance both disappointed. We make relatively nominal changes to our MPL FY24F/FY25F EPS of -1%/+2% reflecting lower claims forecasts, reduced policyholder growth expectations and higher HI operating expenses. Our PT is set at A$3.73 (previously A$3.76). The current operating environment still appears relatively favourable for MPL, but we see the stock as fair value trading on ~19x FY24F PE. HOLD maintained

No news is good news

Pilbara Minerals
3:27pm
February 22, 2024
PLS reported a soft 1H24 earnings result against consensus expectations, but given there was no significant news and the stock is highly shorted, the miss did not move the stock price greatly. 1H24 underlying EBITDA of A$415m was -8% vs Visible Alpha consensus, while underlying NPAT of A$273m was -15% vs consensus. P680 and P1000 projects are on schedule and budget. FY24 capex guidance reduce to manages costs. Maintain our Add rating with a $4.50ps Target Price. Besides the miss a quiet result for PLS. We expect the stock to re-rate in a broader lithium recovery.

Earnings supported by acquisitions and inflation

APA Group
3:27pm
February 22, 2024
We expect c.1% consensus EBITDA downgrades given first-time FY24 EBITDA guidance that at the mid-point indicates 9-10% growth over FY23. No change to DPS guidance. We layer in higher costs and capex beyond FY24. HOLD retained. 12 month target price $7./sh. At current prices, we estimate a 12 month TSR of c.-3% (incl. 6.9% cash yield) and a five year IRR of c.6% pa.

News & Insights

Investment Watch is a flagship product that brings together our analysts' view of economic and investment strategy themes, sector outlooks and best stock ideas for our clients.

Investment Watch is a quarterly publication produced by Morgans that delves into key insights for equity and economic strategy. This latest publication will cover;

  • Asset Allocation – not the time to play defence
  • Economic Strategy – averting a world recession
  • Equity Strategy – attention turns to August
  • Resources & Energy – domestic gas coming to the boil
  • Banks – befuddling
  • Updated Morgans Best Ideas

Morgans clients receive exclusive insights such as access to our latest Investment Watch publication. Download the preview now.

      
View Investment Watch
      

Preview

We think the investment landscape remains favourable. The US economic fundamentals are strong with no significant downside risks to growth in the near-term. European leading indicators suggest a turning point is near and China’s cyclical recovery is still gaining momentum after bottoming earlier in the year.

Meanwhile, the Australian economy continues to defy expectations of a sharper slowdown. In our view, this is not the time to play defence and continue to expect growth assets such as equities and property to do well. This quarter, we look at tactical opportunities in private credit, global equities and across the Australian equity market (resources, agriculture, travel and technology).

Read more
Our best ideas are those that we think offer the highest risk-adjusted returns over a 12-month timeframe supported by a higher-than-average level of confidence. They are our most preferred sector exposures.

As interest rates normalise, earnings quality, market positioning and balance sheet strength will play an important role in distinguishing companies from their peers. We think stocks will continue to diverge in performance at the market and sector level, and investors need to take a more active approach than usual to manage portfolios.

Additions: This month we add Elders.

July best ideas

Elders (ELD)

Small cap | Food/Ag

ELD is one of Australia’s leading agribusinesses. It has an iconic brand, 185 years of history and a national distribution network throughout Australia. With the outlook for FY25 looking more positive and many growth projects in place to drive strong earnings growth over the next few years, ELD is a key pick for us. It is also trading on undemanding multiples and offers an attractive dividend yield.

Technology One (TNE)

Small cap | Technology

TNE is an Enterprise Resource Planning (aka Accounting) company. It’s one of the highest quality companies on the ASX with an impressive ROE, nearly $200m of net cash and a 30-year history of growing its earnings by ~15% and its dividend ~10% per annum. As a result of its impeccable track record TNE trades on high PE. With earnings growth looking likely to accelerate towards 20% pa, we think TNE’s trading multiple is likely to expand from here.

ALS Limited

Small cap | Industrials

ALQ is the dominant global leader in geochemistry testing (>50% market share), which is highly cash generative and has little chance of being competed away. Looking forward, ALQ looks poised to benefit from margin recovery in Life Sciences, as well as a cyclical volume recovery in Commodities (exploration). Timing around the latter is less certain, though our analysis suggests this may not be too far away (3-12 months). All the while, gold and copper prices - the key lead indicators for exploration - are gathering pace.

Clearview Wealth

Small cap | Financial Services

CVW is a challenger brand in the Australian retail life insurance market (market size = ~A$10bn of in-force premiums). CVW sees its key points of differentiation as its: 1) reliable/trusted brand; 2) operational excellence (in product development, underwriting and claims management); and 3) diversified distributing network. CVW's significant multiyear Business Transformation Program has, in our view, shown clear signs of driving improved growth and profitability in recent years. We expect further benefits to flow from this program in the near term, and we see CVW's FY26 key business targets as achievable. With a robust balance sheet, and with our expectations for ~21% EPS CAGR over the next three years, we see CVW's current ~11x FY25F PE multiple as undemanding.

GUD Holdings

Large cap | Consumer Discretionary

GUD is a high-quality business with an entrenched market position in its core operations and deep growth opportunities in new markets. We view GUD’s investment case as compelling, a robust earnings base of predominantly non-discretionary products, structural industry tailwinds supporting organic growth and ongoing accretive M&A optionality. We view the ~12x multiple as undemanding given the resilient earnings and long-duration growth outlook for the business ahead.

Stanmore Resources

Small cap | Metals & Mining

SMR’s assets offer long-life cashflow leverage at solid margins to the resilient outlook for steelmaking coal prices. We’re strong believers that physical coal markets will see future cycles of “super-pricing” well above consensus expectations, supporting further periods of elevated cash flows and shareholder returns. We like SMR’s ability to pay sustainable dividends and its inventory of organic growth options into the medium term, with meaningful synergies, and which look under-recognised by the market. We see SMR as the default ASX-listed producer for pure met coal exposure. We maintain an Add and see compelling value with SMR trading at less than 0.8x P/NPV.


Morgans clients receive full access of the Best Ideas, including our large, mid and small-cap key stock picks.

      
Contact us
      
Read more
There are many reasons to invest in equities. Historically, they have offered higher capital returns than many other asset classes. Furthermore, they provide liquidity and diversification and allow investors to participate in the growth of high performing businesses and sectors.

There are many reasons to invest in equities. Historically, they have offered higher capital returns than many other asset classes. Furthermore, they provide liquidity and diversification and allow investors to participate in the growth of high performing businesses and sectors. Not to be overlooked, however, is their capacity to provide an income stream through regular dividends. In the Month Ahead for July, we highlight a selection of Australian equities that offer superior forecast dividend yields and may be suitable investments for those seeking income.

Happy New Financial Year!

BHP Group (BHP)

BHP Group (ASX: BHP) is the largest diversified mining company in the world. BHP has extensive iron ore, copper, nickel and coal operations, and will soon add potash to its portfolio once its massive Jansen project comes online in late 2026. Besides nickel, which has proven volatile, the rest of BHP’s basket of market exposures share the similar characteristic of typically boasting bumper margins throughout the cycle. Over the last decade BHP has shifted its corporate strategy toward streamlining its business, protecting its balance sheet, slowing its pace of investment and maximising shareholder returns. Despite an impressive shareholder performance over recent years, BHP’s dividend yield has remained above market.

      
BHP coverage report
      

Dalrymple Bay Infrastructure (DBI)

Dalrymple Bay Infrastructure (ASX: DBI). DBI owns a fully contracted coal export terminal in central Qld. It has strong revenue and cost risk mitigants, CPI-linked base revenues boosted by incremental revenues from commissioned sustaining capex projects, very high EBITDA margins, and an investment grade credit profile. Investors comfortable with the coal-related exposure also benefit from the ESG discount imputed into the stock price.

      
DBI coverage report
      

Ventia Services Group (VNT)

Ventia Services Group (ASX: VNT) delivers essential services predominantly to government (c.75% of revenue), with an average contract tenure of c.5-7 years and direct inflation passthrough (95% of revenue) in most contracts. The industry grows at 6-7% pa, with VNT growing 7-10% through industry growth and contract expansion, whilst margins should remain stable. The stock continues to deliver a strong dividend yield, which we expect to continue growing at mid-single digits, whilst trading on an undemanding low double-digit PER.

      
VNT coverage report
      

Eagers Automotive (APE)

Eagers Automotive Limited (ASX: APE) is the leading automotive retail group in Australia and New Zealand, operating for over 100 years and representing a diverse portfolio of OEM (original equipment manufacturer) brands. While current industry dynamics in the auto sector (margin pressure; cost of living impacts) are expected to persist in the near-term, we view the scale operators (such as APE) as best placed to navigate this challenging dynamic. Longer-term, we are positive on APE’s various strategic initiatives and expect it can continue to scale; and sustain a structurally higher return on sales through the cycle.

      
APE research report
      

GQG Partners (GQG)

GQG Partners (ASX: GQG) is global asset management boutique, managing ~US$150bn in funds across four primary equity strategies. We like GQG given its highly effective distribution, scalable strategies, and strong long-term investment performance. We view the earnings tailwind from strong funds under management growth (a combination of investment performance and net fund inflows) will continue and we think GQG will continue to re-rate along with this to a higher earnings multiple in time.

      
GQG research report
      

HomeCo Daily Needs REIT (HDN)

HomeCo Daily Needs REIT (ASX: HDN) has a +$4.5bn real estate portfolio focused on daily needs retail (Large Format Retail; Neighbourhood; and Health Services) across +50 properties with the top five tenants being Woolworths, Coles, JB Hi-Fi, Bunnings and Spotlight. Most of leases are fixed. The portfolio has resilient cashflows, with the majority of tenants being national. Sites are in strategic locations with strong population growth. HDN offers an attractive distribution yield, with a +$600m development pipeline providing further growth.

      
HDN research report
      

IPH Limited (IPH)

IPH Limited (ASX: IPH) is a prominent IP services group with market leading shares in Australia, Singapore and Canada. A defensive business, IPH has strong cash flow generation (with high conversion to EBITDA) and a long-track record of paying dividends to shareholders. We like IPH and consider the return to organic growth (albeit subdued) as a key near-term catalyst for the group. Longer-term, we expect IPH to continue to prosecute its consolidation and network expansion strategy offshore.

      
IPH research report
      

Suncorp (SUN)

Suncorp (ASX: SUN) is well positioned to benefit from continued strong price increases going through the home and motor insurance market in Australia, we expect these price increases to be supportive of SUN’s margins expanding further over the next couple of years. Additionally SUN’s recent divestment of its bank was done at an excellent price and will allow the company to focus completely on its strongest business, general insurance, where it is a market leader.  Finally, post the bank sale, SUN now has >A$4bn of excess capital to return to shareholders, which will occur most likely via the way of a share consolidation and a small special dividend.

      
SUN research report
      

Super Retail Group (SUL)

Super Retail Group (ASX: SUL) is a large discretionary retailer comprising four well-known brands which span several categories, including: Supercheap Auto; rebel Sport; Boating, Camping and Fishing (BCF), and Macpac. We like SUL given its market leading scale (>740 stores), deep data capabilities, strong loyalty base and diversified portfolio of brands. SUL has a very strong net cash balance sheet, and we expect it is positioned for further capital management initiatives in the near-term (i.e. potential special dividends).

      
SUL research report
      

Woodside Energy (WDS)

Woodside Energy (ASX: WDS) is the largest ASX-listed oil and gas producer, and in the top 10 globally. While its share price has come under pressure, Woodside’s fundamentals have benefited from resilient oil/LNG prices, steady group production, progress on delivering its key growth projects, a robust level of profitability, and clear focus on its dividend profile. Woodside’s dividend payout ratio has averaged 80% of earnings for the last +5 years, which is impressive given the last 2 years have been a capex-heavy phase as its progressed construction of the Scarborough, Pluto Train 2, and Sangomar projects. With gearing remaining low and cash flow set to grow post the current investment phase, we see Woodside as likely to remain an attractive yield play.

      
WDS research report
      

Morgans clients receive exclusive insights such as access to the latest stock and sector coverage featured in the Month Ahead. Contact us today to begin your journey with Morgans.

      
Contact Us
      
Read more